Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial

NCT05072314 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

4300

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Breast Cancer Female
Breast Conserving Surgery
Mastectomy

Interventions

DRUG: lidocaine 2% and 10%
DRUG: Placebo

Sponsor

Monash University

Collaborators

[object Object]